Immunitybio Inc (IBRX)

R&D Expense Growth

-10.93%

Quarterly · Period ending:

IBRX logo

IBRX R&D Expense Growth

Latest reported-10.93%
IBRX Quarterly R&D Growth (QoQ) (0.00% → -10.93%)
High-resolution chart · PNG

IBRX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-10.931%
6.5156%
19.8612%
-8.1541%
14.5167%
36.9467%
-30.1766%
-1.3417%
-4.1649%
3.5298%
6.4667%
-8.964%
-32.4971%
49.0303%
-21.2496%
14.4514%
14.3308%
-0.8985%
5.0247%
-8.4071%
30.8111%
103.0411%
-43.3747%
8.3836%
20.5706%
107.4888%
9.4673%
-8.2172%
4.2308%
0.9455%
-14.2798%
-0.8783%
4.9818%
16.388%
8.6006%
14.0429%
4.9524%
-2.0858%
12.9244%
30.9125%
29.2273%
-3.1727%
29.2658%
126.361%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.